Evidence map›Paper›PMID 26301497›Full record

ArticleNature genetics2015

Genetic association analyses highlight biological pathways underlying mitral valve prolapse.

Christian Dina, Nabila Bouatia-Naji, Nathan Tucker, Francesca N Delling, Katelynn Toomer, Ronen Durst, Maelle Perrocheau, Leticia Fernandez-Friera, Jorge Solis, PROMESA investigators and 32 more

Open access · greenAbstract read
In one paragraph

Article in Nature genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed, 2 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 2 syntheses or guidelines pooled it, 130 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Recent advances in omics-based research of mitral valve disease.Frontiers in cardiovascular medicine · 2026
    Review
  5. Review
  6. Review
  7. Mechanisms of mitral valve development and disease.Frontiers in cardiovascular medicine · 2026
    Review
  8. Review
  9. Zebrafish in Cardiovascular Disease Research: from Model to Application.International journal of biological sciences · 2026
    Review
  10. Article
  11. Review
  12. Article
  13. Recessive genetic contribution to congenital heart disease in 5,424 probands.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Valvulopathies and Genetics: Where are We?Reviews in cardiovascular medicine · 2024
    Review

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

42 authors at 12 institutions in 6 countries.

Christian DinaINSERM Unité Mixte de Recherche (UMR) 1087, Centre National de la Recherche Scientifique (CNRS) UMR 6291, Institut du Thorax, Nantes, France.ORCID http://orcid.org/0000-0002-7722-7348
Nabila Bouatia-NajiINSERM UMR 970, Paris Cardiovascular Research Center, Paris, France.
Nathan TuckerCardiovascular Research Center, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
Francesca N DellingFramingham Heart Study, Population Sciences Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, US National Institutes of Health, Framingham, Massachusetts, USA.
Katelynn ToomerDepartment of Regenerative Medicine and Cell Biology, Cardiovascular Developmental Biology Center, Children's Research Institute, Medical University of South Carolina, Charleston, South Carolina, USA.
Ronen DurstDepartment of Cardiology, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
Maelle PerrocheauINSERM UMR 970, Paris Cardiovascular Research Center, Paris, France.
Leticia Fernandez-FrieraHospital Universitario Montepríncipe, Universidad Centro de Estudios Universitarios (CEU) San Pablo, Madrid, Spain.
Jorge SolisHospital Universitario Montepríncipe, Universidad Centro de Estudios Universitarios (CEU) San Pablo, Madrid, Spain.ORCID http://orcid.org/0000-0002-4227-7062
PROMESA investigators
Thierry Le TourneauINSERM Unité Mixte de Recherche (UMR) 1087, Centre National de la Recherche Scientifique (CNRS) UMR 6291, Institut du Thorax, Nantes, France.
Ming-Huei ChenFramingham Heart Study, Population Sciences Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, US National Institutes of Health, Framingham, Massachusetts, USA.
Vincent ProbstINSERM Unité Mixte de Recherche (UMR) 1087, Centre National de la Recherche Scientifique (CNRS) UMR 6291, Institut du Thorax, Nantes, France.
Yohan BosseInstitut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University, Quebec City, Quebec, Canada.
Philippe PibarotInstitut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University, Quebec City, Quebec, Canada.
Diana ZelenikaCentre National de Génotypage, Evry, France.
Mark LathropCentre National de Génotypage, Evry, France.
Serge HercbergParis Descartes University, Paris Sorbonne Cité, Paris, France.
Ronan RousselParis Diderot University, Paris, France.
Emelia J BenjaminFramingham Heart Study, Population Sciences Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, US National Institutes of Health, Framingham, Massachusetts, USA.ORCID http://orcid.org/0000-0003-4076-2336
Fabrice BonnetINSERM, Clinical Investigation Centre (CIC) 0203, University Hospital of Pontchaillou, Rennes, France.
Su Hao LoDepartment of Biochemistry and Molecular Medicine, School of Medicine, University of California, Davis, Davis, California, USA.
Elena DolmatovaCardiovascular Research Center, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
Floriane SimonetINSERM Unité Mixte de Recherche (UMR) 1087, Centre National de la Recherche Scientifique (CNRS) UMR 6291, Institut du Thorax, Nantes, France.
Simon LecointeINSERM Unité Mixte de Recherche (UMR) 1087, Centre National de la Recherche Scientifique (CNRS) UMR 6291, Institut du Thorax, Nantes, France.
Florence KyndtINSERM Unité Mixte de Recherche (UMR) 1087, Centre National de la Recherche Scientifique (CNRS) UMR 6291, Institut du Thorax, Nantes, France.
Richard RedonINSERM Unité Mixte de Recherche (UMR) 1087, Centre National de la Recherche Scientifique (CNRS) UMR 6291, Institut du Thorax, Nantes, France.
Hervé Le MarecINSERM Unité Mixte de Recherche (UMR) 1087, Centre National de la Recherche Scientifique (CNRS) UMR 6291, Institut du Thorax, Nantes, France.
Philippe FroguelCNRS UMR 8199, Lille Pasteur Institute, Lille 2 University, European Genomic Institute for Diabetes (EGID), Lille, France.
Patrick T EllinorCardiovascular Research Center, Massachusetts General Hospital, Charlestown, Massachusetts, USA.ORCID http://orcid.org/0000-0002-2067-0533
Ramachandran S VasanFramingham Heart Study, Population Sciences Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, US National Institutes of Health, Framingham, Massachusetts, USA.
Patrick BrunevalINSERM UMR 970, Paris Cardiovascular Research Center, Paris, France.
Roger R MarkwaldDepartment of Regenerative Medicine and Cell Biology, Cardiovascular Developmental Biology Center, Children's Research Institute, Medical University of South Carolina, Charleston, South Carolina, USA.
Russell A NorrisDepartment of Regenerative Medicine and Cell Biology, Cardiovascular Developmental Biology Center, Children's Research Institute, Medical University of South Carolina, Charleston, South Carolina, USA.
David J MilanCardiovascular Research Center, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
Susan A SlaugenhauptCenter for Human Genetic Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Robert A LevineCardiac Ultrasound Laboratory, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Jean-Jacques SchottINSERM Unité Mixte de Recherche (UMR) 1087, Centre National de la Recherche Scientifique (CNRS) UMR 6291, Institut du Thorax, Nantes, France.
Albert A HagegeINSERM UMR 970, Paris Cardiovascular Research Center, Paris, France.
MVP-France
Xavier JeunemaitreINSERM UMR 970, Paris Cardiovascular Research Center, Paris, France.ORCID http://orcid.org/0000-0001-5925-381X
Leducq Transatlantic MITRAL Network
Centre National de la Recherche Scientifique · FRDélégation Paris 5 · FRBeth Israel Deaconess Medical Center · USHarvard University · USInserm · FRUniversidad San Pablo CEU · ESBoston University · USBroad Institute · USGenome Canada · CAHadassah Medical Center · ILMassachusetts General Hospital · USMedical University of South Carolina · US

Funding

PHARMACOGENOMICS OF ARRHYTHMIA THERAPYU01HL065962 · NHLBI · VANDERBILT UNIVERSITY · PI RODEN, DAN M · 2001 to 2009
$24.8M
IDENTIFICATION OF COMMON GENETIC VARIANTS FOR ATRIAL FIBRILLATION AND PR INTERVALR01HL092577 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI BENJAMIN, EMELIA J., ELLINOR, PATRICK THOMAS · 2009 to 2025
$20.6M
Pharmacogenomics of Arrhythmia TherapyU19HL065962 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RODEN, DAN M · 2010 to 2014
$17.4M
MULTIDISCIPLINARY RESEARCH TRAINING IN CARDIOLOGYT32HL007208 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI Patrick Thomas Ellinor, David E Sosnovik · 1985 to 2026
$16.1M
Targeted Nano-therapeutics for Neural RegenerationP20GM103444 · NIGMS · CLEMSON UNIVERSITY · PI SIMIONESCU, AGNETA · 2012 to 2018
$14.9M
SC COBRE for Developmentally Based Cardiovascular DiseasesP30GM103342 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MARKWALD, ROGER R · 2012 to 2016
$5.5M
MUCOPOLYSACCHRIDE METABOLISM IN CARDIAC ANOMALIESR01HL033756 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MARKWALD, ROGER R · 1985 to 2015
$4.8M
Effect of Mitral Regurgitation on Ischemic LV RemodelingR01HL072265 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI LEVINE, ROBERT A · 2003 to 2013
$3.5M
Improving Mitral Compensation in Ischemic RegurgitationR01HL109506 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI AIKAWA, ELENA, BISCHOFF, JOYCE E. · 2012 to 2015
$3.3M
Genetics and Mechanisms of Mitral Valve ProlapseR01HL127692 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI MILAN, DAVID J, SLAUGENHAUPT, SUSAN A · 2015 to 2018
$3.0M
EXTRAMURAL RESEARCH FACILITIES CONSTRUCTIONC06RR018823 · NCRR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI RAYMOND, JOHN R · 2003 to 2003
$2.9M
Treating Ventricle and Valve: New Synergies for Ischemic LV Remodeling with MRR01HL128099 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI AKAR, FADI GABRIEL, LEVINE, ROBERT A · 2016 to 2019
$2.8M
CIHR MOP-102481CIHR MOP-102737CIHR MOP-114997CIHR MOP-126072CIHR MOP-137058NCRR NIH HHS C06 RR018823NHLBI NIH HHS HL065962NHLBI NIH HHS HL092577NHLBI NIH HHS HL104156NHLBI NIH HHS HL109506NHLBI NIH HHS K23 HL116652NHLBI NIH HHS K24 HL067434NHLBI NIH HHS K24 HL105780NHLBI NIH HHS K24HL105780NHLBI NIH HHS K24 HL67434NHLBI NIH HHS R01 HL072265NHLBI NIH HHS R01 HL092577NHLBI NIH HHS R01 HL104156NHLBI NIH HHS R01 HL109004NHLBI NIH HHS R01 HL109506NHLBI NIH HHS R01 HL127692NHLBI NIH HHS R01-HL127692NHLBI NIH HHS R01 HL128099NHLBI NIH HHS R01-HL33756NHLBI NIH HHS R01 HL72265NHLBI NIH HHS T32 HL007208NHLBI NIH HHS U01 HL065962NHLBI NIH HHS U19 HL065962NIGMS NIH HHS 1P30 GM103342NIGMS NIH HHS 8P20 GM103444-07
6 · The paper itself

Abstract

Nonsyndromic mitral valve prolapse (MVP) is a common degenerative cardiac valvulopathy of unknown etiology that predisposes to mitral regurgitation, heart failure and sudden death. Previous family and pathophysiological studies suggest a complex pattern of inheritance. We performed a meta-analysis of 2 genome-wide association studies in 1,412 MVP cases and 2,439 controls. We identified 6 loci, which we replicated in 1,422 cases and 6,779 controls, and provide functional evidence for candidate genes. We highlight LMCD1 (LIM and cysteine-rich domains 1), which encodes a transcription factor and for which morpholino knockdown of the ortholog in zebrafish resulted in atrioventricular valve regurgitation. A similar zebrafish phenotype was obtained with knockdown of the ortholog of TNS1, which encodes tensin 1, a focal adhesion protein involved in cytoskeleton organization. We also showed expression of tensin 1 during valve morphogenesis and describe enlarged posterior mitral leaflets in Tns1(-/-) mice. This study identifies the first risk loci for MVP and suggests new mechanisms involved in mitral valve regurgitation, the most common indication for mitral valve repair.

Indexed as

AnimalsCase-Control StudiesGenome-Wide Association StudyHumansMiceMitral Valve Prolapse

Identifiers

PMID26301497
PMCPMC4773907
OpenAlexW2266573952

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.